Nucleotide synthesis—the production of the basic components of DNA and RNA—is essential for cell growth and division. In most ...

Living cells are sustained by countless chemical reactions that must be carefully regulated to maintain internal order and ...

Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...

California-based fusion start-up Inertia Enterprises has raises $450m to commercialise laser-driven inertial fusion and build grid-scale power plants.

Traditional cell therapies rely on “clean targets” – antigens that are found on cancer cells but not on healthy cells. Where these targets can’t be found, it’s difficult to build a therapy that will ...

Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular ...

Chemical structure of imatinib, a precision cancer drug containing an amide bond. Xiaoguang Lei and his team used their engineered enzyme to streamline the synthesis of imatinib, a landmark cancer ...

A Knoxville nuclear company backed by Bill Gates has asked Tennessee for a license to help it build the world’s first fusion plant. Type One Energy, which plans to build the Infinity One prototype ...

The Taylor vortex fermenter-extractor-separator is designed for small volume, value-added cellular products and process intensification.

California firm founders, including two US Energy Dept. veterans, aim to scale laser-based inertial confinement fusion ...

Inertia Enterprises has raised $450 million to build one of the world’s most powerful lasers, which it hopes will serve as the foundation of a grid-scale power plant the fusion startup intends to ...

Grafting is a widely used agricultural technique, but the slow and unreliable healing of graft unions often limits its efficiency.